Complications in two children with acute lymphatic leukemia caused by vaccination against varicella zoster virus;Komplikationer hos to born med akut lymfatisk leukaemi vaccineret mod varicella zoster-virus

Ugeskrift for Laeger

Volumn 161, Issue 6, 1999, Pages 794-796

  Christensen, Laurids Siig ^a   Poulsen, Anja ^b   Böttiger, Blenda ^b   Kirk, Marshall ^b   Andersen, Hans Kerzel ^b   Schmiegelow, Kjeld ^b  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; LIVE VACCINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BASE PAIRING; CASE REPORT; CHICKENPOX; CHILD; HUMAN; POLYMERASE CHAIN REACTION; REMISSION; VACCINATION; VARICELLA ZOSTER VIRUS; FEMALE; GENETICS; HERPES ZOSTER; IMMUNE DEFICIENCY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; PRESCHOOL CHILD;

CHICKENPOX; CHICKENPOX VACCINE; CHILD, PRESCHOOL; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; VACCINES, ATTENUATED;

EID: 0033534835     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Takahaski M, Otsuku T, Okuno Y, Asano Y, Yazaki T, Isomura S. Live vaccine to prevent the spread of varicella in children in hospital. Lancet 1974; II: 1288-90.
2. Weller TH. Varicella: historical perspective and clinical overview. J Infect Dis 1996; 174 (suppl 3): S306-9.
3. Gershon AA, Steinberg SP, Gelb L, Galassso G, Borkowaky W, LaRussa P et al. Live attenuated varicella vaccine. JAMA 1984; 252: 355-62.
4. Gershon AA, Steinberg SP, Gelb L, Galasso G, Borkowaky W, LaRussa P et al. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med 1989; 320: 892-7.
5. Brunell PA, Geiser CF, Novelli V, Lipton S, Narkewicz S. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia. Pediatrics 1987; 79: 922-7.
6. Asano Y. Varicella vaccine: the Japanese experience. J Infect Dis 1996;174(suppl 3): S310-3.
7. Varis T, Vesikari T. Efficacy of high-liter live attenuated varicella vaccine in healthy young children. J Infect Dis 1996; 174(suppl 3): S330-4.
8. Meurice F, de Bouver J-L, Vandevoorde D, Woods S, Bogaerts H. Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children. J Infect Dis 196; 174(suppl 3): S324-9.
9. LaRussa P, Steinberg S, Gershon AA. Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada. J Infect Dis 1996; 174(suppl 3): S320-3.
10. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type Varicella-zoster virus isolates. J Virol 1992; 66: 1016-20.
11. Takada M, Suzutani T, Yoshida I, Matoba M, Azuma M. Identification of Varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region. J Clin Microbiol 1995; 33: 658-60.
12. Christensen LS. The population biology of suid Herpesvirus 1. APMIS 1995; 103 (suppl 48).
13. Tsolia M, Gershon AA, Steinberg SP, Gelb L and the National Institute of Allergy and infectious Diseases Varicella Vaccine Collaborative Study Group. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. J Pediatr 1990: 116: 184-9.